Chest
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines
Section snippets
Historical Perspective
The development of cardiac catheterization provided the first method to diagnose and confirm PAH, and was the pivotal diagnostic method for 3 decades after the first clinical description of idiopathic PAH (IPAH) in the early 1950s. Although cardiac catheterization is still necessary for disease confirmation in patients with suspected pulmonary hypertension (PH), in the current era it rarely reveals unsuspected new findings. The technical advances in noninvasive thoracic and cardiac imaging over
Evaluation of PAH
Assessment of PAH is based on a logical sequence of determining whether there is a risk of PAH being present, whether PAH is likely to be present based on initial, noninvasive evaluation, clarifying the underlying etiology of PAH in an individual patient, and delineating the specific hemodynamic profile, including the acute response to vasodilator testing. The schema for patient evaluation using this approach is provided in Figure 1, and is expanded in the text.
Genetic Screening for Mutations That Cause PAH
Mutations in the bone morphogenetic protein receptor II (BMPR2) gene have been identified in approximately 50% of patients with familial PAH (FPAH)12 and 25% of patients thought to have sporadic IPAH.3 Other FPAH families demonstrate linkage to the same chromosomal region, 2q32, where BMPR2 resides, but the responsible mutations have not been identified. Confirmation of linkage of any FPAH locus, other than 2q32, has not been reported to date. FPAH is inherited in an autosomal dominant manner
Echocardiographic Screening of Asymptomatic Subjects at Risk for PAH
Few reports have evaluated echocardiography for screening asymptomatic patients with PAH, since the incidence of disease is low and Bayesian analysis would predict a large number of false-positive test results. Furthermore, health insurers may not reimburse the expense of testing “asymptomatic” individuals. Finally, whether establishing an early diagnosis of PAH (such as in a presymptomatic phase of FPAH) improves outcome is unknown, although it unquestionably has important emotional and social
Presenting Symptoms
Patients with PAH generally present with a spectrum of symptoms attributable to impaired oxygen transport and reduced cardiac output. Although PAH may be asymptomatic, particularly in its early stages, exertional dyspnea is the most frequent presenting symptom, and was present in 60% of patients in the National Institutes of Health (NIH) prospective cohort study of patients with PPH.8 Dyspnea is eventually present in virtually all patients as the disease progresses. Fatigue, weakness, or
Physical Examination
Signs of PH on physical examination are subtle and often overlooked. Although no rigorous analysis of the sensitivity and specificity of findings on physical examination has been performed, experience suggests that the likelihood of PAH is increased when certain findings are present. For example, an accentuated pulmonary component of the second heart sound audible at the apex is noted in > 90% of patients with IPAH,8 reflecting increased force of pulmonary valve closure due to elevated
ECG
PAH results in right ventricular hypertrophy and right-heart dilation. Since these processes produce ECG abnormalities, the ECG may provide a signal of hemodynamically significant PH. Right ventricular hypertrophy and right-axis deviation on ECG are seen in 87% and 79%, respectively, of patients with IPAH.8 ECG findings suggestive of PAH are as follows: (1) right-axis deviation; (2) a tall R wave and small S wave with R/S ratio > 1 in lead V1; (3) qR complex in lead V1; (4) rSR' pattern in lead
Chest Radiography
The chest radiograph (CXR) may disclose abnormal anatomic features due to the presence of PAH. Although most patients with asymptomatic PAH have normal CXR findings, the accuracy of the CXR in detecting PAH is unknown. An index has been described based on the ratio of the summed horizontal measurements of the pulmonary arteries from midline to their first divisions divided by the transverse chest diameter.14 All 50 patients with a sPAP < 30 mm Hg, and 10 of 100 patients with a sPAP > 45 mm Hg
Diagnostic Strategies for IPAH
Once PAH is suspected based on the presenting features, screening examination, or incidental discovery during evaluation of apparently unrelated problems, further evaluation is intended to characterize the type of PH and establish its severity. The goal of this approach is to determine prognosis and establish an appropriate treatment strategy. As with assessment strategies for many diseases, this is a hierarchical process beginning with tests that are less invasive and complex but also less
Summary
A high level of suspicion is of paramount importance for the diagnosis of PAH, regardless of the underlying cause. Once suspected, a methodical workup using commonly employed diagnostic interventions allows both confirmation of the presence of PAH and elucidation of its etiology. Clarification of etiology is necessary to ensure that the proper therapeutic interventions are implemented. A diagnostic algorithm that is accepted among experienced centers (Fig 1) can guide the evaluation of PAH.
Summary of Recommendations
- •
Genetic testing and professional genetic counseling should be offered to relatives of patients with FPAH. Level of evidence: expert opinion; benefit: intermediate; grade of recommendation: E/A.
- 2.
Patients with IPAH should be advised about the availability of genetic testing and counseling for their relatives. Level of evidence: expert opinion; benefit: intermediate; grade of recommendation: E/A.
- 3.
In patients with a suspicion of PAH, ECG should be performed to screen for a spectrum of cardiac
References (169)
- et al.
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension
Am J Hum Genet
(2001) - et al.
Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease
Chest
(2002) - et al.
Prevalence of pulmonary hypertension in limited and diffuse scleroderma
Chest
(1996) - et al.
The prognostic role of the ECG in primary pulmonary hypertension
Chest
(2002) - et al.
A radiologic index of pulmonary arterial hypertension
Chest
(1975) - et al.
Assessment of right atrial pressure with two-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study
Mayo Clin Proc
(2000) - et al.
Frequency of Doppler measurable pulmonary artery pressures
J Am Soc Echocardiogr
(1996) - et al.
Echocardiographic features of primary pulmonary hypertension
J Am Soc Echocardiogr
(1999) - et al.
Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates
Liver Transpl
(2000) - et al.
Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion
J Am Coll Cardiol
(1997)
Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients
J Am Coll Cardiol
Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure
J Am Coll Cardiol
Noninvasive estimation of pulmonary artery diastolic pressure in patients with tricuspid regurgitation by Doppler echocardiography
Chest
Prediction of pulmonary arterial pressure in adults by pulsed Doppler echocardiography
Am J Cardiol
Shortening of Doppler-derived deceleration time of early diastolic transmitral flow in the presence of pulmonary hypertension through ventricular interaction
Am J Cardiol
Evaluation of the responsiveness of elevated pulmonary vascular resistance in children by Doppler echocardiography
J Am Coll Cardiol
Doppler echocardiographic prediction of pulmonary arterial hypertension in congenital heart disease
Am J Cardiol
Early partial systolic closure of the pulmonic valve relates to severity of pulmonary hypertension
Am Heart J
A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension
Am J Obstet Gynecol
Clinical predictors of pulmonary hypertension in patients undergoing liver transplant evaluation
Liver Transpl
Is noninvasive determination of pulmonary artery pressure feasible using deceleration phase Doppler flow velocity characteristics in mechanically ventilated children with congenital heart disease?
Am J Cardiol
Antinuclear antibodies in primary pulmonary hypertension
J Am Coll Cardiol
Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku
Am J Med
Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis
Am J Med
The pulmonary pathologic manifestations of the CREST syndrome
Hum Pathol
Prevalence of pulmonary hypertension in limited and diffuse scleroderma
Chest
Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease
Chest
The left ventricle in systemic lupus erythematosus: initial observations and a five-year follow-up in a university medical center population
Am Heart J
Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases
Mayo Clin Proc
Primary pulmonary hypertension in HIV infection
Chest
Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension
Chest
Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome
J Am Coll Cardiol
Involvement of nuclear factor-κB in a murine model for the acute form of autoimmune-like toxic oil syndrome
Toxicol Appl Pharmacol
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Blood
Pulmonary hypertension in patients with end-stage renal disease
Chest
Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics
Gastroenterology
Severe pulmonary hypertension in liver transplant candidates
Liver Transpl Surg
Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension: the International PPH Consortium
Nat Genet
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family
J Med Genet
Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension
Am J Respir Crit Care Med
Genetic abnormalities in hereditary hemorrhagic telangiectasia
Curr Opin Hematol
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
N Engl J Med
Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene
Circulation
Primary pulmonary hypertension: a national prospective study
Ann Intern Med
Primary pulmonary hypertension: executive summary
Pulmonary veno-occlusive disease: a case series and new observations
Chest
Radiographic findings in pulmonary hypertension from unresolved embolism
AJR Am J Roentgenol
Pulmonary hypertension in patients with chronic pulmonary thromboembolism: chest radiograph and CT evaluation before and after surgery
Eur Radiol
Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes
Jpn Circ J
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension: Primary Pulmonary Hypertension Study Group
Circulation
Cited by (757)
Application of DNA Nanotweezers in biosensing: Nanoarchitectonics and advanced challenges
2023, Biosensors and BioelectronicsPredicting the Severity and Outcome of Persistent Pulmonary Hypertension of the Newborn Using New Echocardiography Parameters
2023, Current Problems in CardiologyPulmonary Hypertension in Scleroderma– Evaluation and Management
2023, Disease-a-MonthACR Appropriateness Criteria® Suspected Pulmonary Hypertension: 2022 Update
2022, Journal of the American College of RadiologyCitation Excerpt :There are complementary procedures (ie, more than one procedure is ordered as a set or simultaneously where each procedure provides unique clinical information to effectively manage the patient’s care). PH tends to present with nonspecific symptoms; thus, chest radiography is often the first imaging test performed [11]. Multiple historic studies have shown that chest radiography is a useful study in the initial evaluation of PH [13-19].
For financial disclosure information see page 1S.